Notably, KDM3A has become relevant to tumour progression due to recent findings of this enzyme’s role in promoting cancerous phenotypes, such as enhanced glucose consumption and upregulated mechanisms of chemoresistance. This evidence concerns the gene KDM3A and neoplasm.